AI BriefingMindset Health
Key point
Mindset Health leverages ElevenLabs' TTS technology to deliver personalized digital therapeutics, achieving high treatment adherence.
Details
Mindset Health develops clinically validated digital therapeutics aimed at the interaction between brain activity and physical health. Its flagship program, Nerva, uses gut-directed hypnotherapy to help manage gastrointestinal conditions such as Irritable Bowel Syndrome (IBS).
To improve accessibility and adherence, the company integrated ElevenLabs' Text to Speech (TTS) and Voice Cloning technology. This enables the delivery of high-quality audio experiences at scale.
Synthetic voice goes beyond simple guidance, serving as a core therapeutic element for retraining gut-brain signaling. The team rapidly tests and deploys personalized voice protocols with varying tones, speeds, and regional accents.
Key results include:
- Maintaining a high session completion rate of 85-90%
- A/B testing showed no difference in preference between studio recordings and AI-generated dialogue
- Rapid iteration and optimization of voice elements based on user feedback
This summary was generated automatically by AI. Check the original for the author's claims and context. Copyright belongs to the original author.
Our guide explains how the AI works. Report summary errors, attribution issues, or removal requests via Contact.
Related
Halo NeuroAI Releases Sopro V2 Turbo, a 120M-Parameter Open-Source Voice Cloning TTS with Native European Portuguese Support